[Combined radiotherapy and endovascular x-ray therapy for invasive cancer of the urinary bladder]
/in Dendritic Cells, International Publications, Urothelial Carcinoma /von 2005-01-01 / Vopr Onkol 2005;51(6):685-8Toward personalized immunotherapy for non-Hodgkin lymphoma: targeting the idiotypic immunoglobulin
/in International Publications, Malignant Lymphoma /von 2005-01-01 / BioDrugs 2005;19(5):289-97Effects of PSK on T and dendritic cells differentiation in gastric or colorectal cancer patients
/in Gastric Cancer, International Publications /von 2005-01-01 / Anticancer Res. 2005 Jan-Feb;25(1B):443-9Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: correlation with HSP 70 expression and composition of splenic lymphocytes
/in Hyperthermia, International Publications, Malignant Melanoma /von 2005-01-01 / Immunol. Invest. 2005;34(3):245-58Regional hyperthermia in conjunction with definitive radiotherapy against recurrent or locally advanced prostate cancer T3 pN0 M0
/in Hyperthermia, International Publications, Prostate Cancer /von 2005-01-01 / Strahlenther Onkol 2005 Jan;181(1):35-41Effects of febrile temperature on adenoviral infection and replication: implications for viral therapy of cancer
/in Hyperthermia, International Publications, Newcastle Disease Virus /von 2005-01-01 / J. Virol. 2005 Jan;79(1):581-91Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy
/in Cervical Cancer, Dendritic Cells, International Publications /von 2005-01-01 / Curr. Pharm. Des. 2005;11(27):3485-500Current status of vaccination therapy for leukemias
/in Chronic Leukemia, International Publications /von 2005-01-01 / Curr. Hematol. Rep. 2005 Jan;4(1):73-6The anti-tumor effect of interleukin-12 is enhanced by mild (fever-range) thermal therapy
/in Hyperthermia, International Publications /von 2005-01-01 / Immunol. Invest. 2005;34(3):361-80
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de